Evidence-Based Hair
J

Androgenetic Alopecia: Metabolic Syndrome, Perifollicular Inflammation and Relative Efficacy of Minoxidil and the 5-alpha Reductase Inhibitors

By Evidence-Based Hair FEATURING Jeff Donovan
By Evidence-Based Hair FEATURING Jeff Donovan
0 views
September 29, 2022
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
09:09
Sergio Vano

Safety of Low-Dose Oral Minoxidil for Hair Loss: Multicenter Study o…

05:49
Evidence-Based Hair

The Effects of Oral Minoxidil on Nails

Feat. J. Donovan
24:13
Evidence-Based Hair

Relative Efficacy of Minoxidil and Monotherapy with 5-Alpha Reductas…

Feat. J. Donovan
56:38
Diversity in Dermatology

The Approach to CCCA

Feat. E. Kaminska
06:51
Evidence-Based Hair

Genetics of Male Frontal Fibrosing Alopecia

Feat. J. Donovan
13:02
Evidence-Based Hair

Baricitinib for Pediatric Alopecia Areata: Promising Results and Fut…

Feat. J. Donovan
30:15
Stephen Stone

Practical Practice Pearls

21:45
Emmy Graber

What's Hot and New in Cosmeceuticals!

30:39
Abdulhadi Jfri

Defining Severe Alopecia Areata and Treatment Updates

10:31
Natasha Mesinkovska

Alopecia Areata: Current Perspectives on Disease Classification, Man…

18:02
Lynne Goldberg

The Hair Loss Patient: How to Get Started

54:59
Evidence-Based Hair

Frontal Fibrosing Alopecia Risks, Hair Transplant Surgery Patient Se…

Feat. J. Donovan
09:39
Ronda Farah

Management Strategies for Non-Scarring Alopecias

14:07
Evidence-Based Hair

Central Centrifugal Cicatricial Alopecia (CCCA): Clinical Factors an…

Feat. J. Donovan
17:19
Antonella Tosti

Alopecia Areata Treatment Regimen: Dosage, Schedule, and the Duratio…

22:37
Loren Krueger

Updates in Central Centrifugal Cicatricial Alopecia

21:24
Evidence-Based Hair

Generic Tofacitinib for Treating Alopecia Areata

Feat. J. Donovan
41:47
Evidence-Based Hair

A Real World Study of Baricitinib Response Timing

Feat. J. Donovan
34:59
Evidence-Based Hair

Treatment Considerations for Scarring Alopecia Under Immune Checkpoi…

Feat. J. Donovan
16:56
Emmy Graber

Isotretinoin Update: What's New in the Literature (Part 2)